Indivior logo

INDV - Indivior News Story

134p 0.8  0.6%

Last Trade - 16/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £984.4m
Enterprise Value £570.1m
Revenue £467.8m
Position in Universe 438th / 1819

Indivior PLC - Total Voting Rights

Mon 1st February, 2021 8:00am
RNS Number : 4288N
Indivior PLC
01 February 2021
 

INDIVIOR PLC (THE 'COMPANY') - TOTAL VOTING RIGHTS AND CAPITAL

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at February 1, 2021 the Company's issued share capital consisted of 734,054,040 Ordinary Shares of US$0.10 each.  The Company does not hold any shares in Treasury.

 

Therefore, the total number of voting rights in the Company is 734,054,040. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Kathryn Hudson

Company Secretary

 

February 1, 2021

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUKANRAVUAUAR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.